Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSainsbury's Regulatory News (SBRY)

Share Price Information for Sainsbury's (SBRY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 256.80
Bid: 256.40
Ask: 257.20
Change: 1.80 (0.71%)
Spread: 0.80 (0.312%)
Open: 256.80
High: 256.80
Low: 256.80
Prev. Close: 255.00
SBRY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - J SAINSBURY PLC

27 Jul 2016 11:46

RNS Number : 3977F
Societe Generale SA
27 July 2016
 

 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Société Générale S.A.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

J SAINSBURY PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

26/07/2016

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

Home Retail Group Plc

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

 

Ordinary: 4,652,866 Shares interests and 14,739,445

 short position

 

ADR (referencing the ordinary) : 23,504 equivalent Shares interests and 0 equivalent Shares as short position

Where (1 ADR = 4 ordinary share)

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

4,676,370

0.24

14,739,445

0.77

(2) Cash-settled derivatives:

 

11,963,427

0.62

1,943

0.00

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

7,222,000

0.38

4,534,253

0.24

 

TOTAL:

23,861,797

1.24

19,275,641

1.00

 

 

 

Class of relevant security:

 

Convertible bonds due November 2019

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

5,500,000

1.22

0

0.00

(2) Cash-settled derivatives:

 

0

0.00

0

0.00

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0.00

0

0.00

 

TOTAL:

5,500,000

1.22

0

0.00

 

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

Number of securities

Price per unit

Ordinary

Purchase

34

2.231

Ordinary

Purchase

1

2.232

Ordinary

Purchase

29,540

2.2386212

Ordinary

Purchase

37

2.238

Ordinary

Purchase

124,443

2.2579476

Ordinary

Purchase

15

2.239

Ordinary

Purchase

68,920

2.2329794

Ordinary

Purchase

20,585

2.2413976

Ordinary

Purchase

73,647

2.231

Ordinary

Sale

6,738

2.2381

Ordinary

Sale

2,720

2.231

Ordinary

Sale

61,657

2.2385925

Ordinary

Sale

56,666

2.231

Ordinary

Sale

194,629

2.2400845

Ordinary

Sale

54

2.231

Ordinary

Sale

54,673

2.2373647

Ordinary

Sale

13,156

2.2340141

Ordinary

Sale

1,011

2.25

Ordinary

Sale

3,643

2.231

Ordinary

Sale

2,099

2.227733

Total Purchases

317,222

Total Sales

397,046

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

YES

 

 

Date of disclosure:

27/07/2016

Contact name:

Olivier Vero

Telephone number:

+44 20 7676 6821 / 6969

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

 

 

 

 

 

SUPPLEMENTAL FORM 8 (OPEN POSITIONS)

 

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the "Code")

 

 

1. KEY INFORMATION

 

Full name of person making disclosure:

Société Générale S.A.

Name of offeror/offeree in relation to whose relevant securities the disclosure relates:

J SAINSBURY PLC

 

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

 

Class of relevant security

Product description e.g. call option

Written or purchased

Number of securities to which option or derivative relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Ordinary

Euro Medium Term Note

Sale

3,253

N/A

N/A

28/04/2017

Ordinary

Listed Call-option

Purchase

22,000

2.8

American options

16/06/2017

Ordinary

Listed put-option

Purchase

1,005,000

2.4

American options

16/12/2016

Ordinary

Listed put-option

Purchase

750,000

2.6

American options

21/12/2018

Ordinary

Listed put-option

Purchase

10,000

2.5

American options

15/12/2017

Ordinary

Listed put-option

Purchase

1,040,000

2.6

American options

15/12/2017

Ordinary

Listed put-option

Purchase

76,000

2.4

American options

15/12/2017

Ordinary

Listed put-option

Purchase

1,600,000

2.2

American options

17/03/2017

Ordinary

Listed put-option

Purchase

50,000

2.4

American options

16/06/2017

Ordinary

Listed put-option

Sale

3,600,000

1.6

American options

18/09/2020

Ordinary

Listed put-option

Sale

3,600,000

1.8

American options

19/03/2021

 

 

3. AGREEMENTS TO PURCHASE OR SELL ETC.

 

Full details should be given so that the nature of the interest or position can be fully understood:

 

 

 

 

 

 

It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.

 

The currency of all prices and other monetary amounts should be stated.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETBDLFLQDFZBBL
Date   Source Headline
27th Nov 20201:30 pmRNSDirector/PDMR Shareholding
17th Nov 202012:00 pmRNSResponse to press speculation
12th Nov 20202:51 pmRNSAdjustment of Conversion Price
5th Nov 20207:00 amRNSHalf-year Report
2nd Nov 20202:20 pmRNSTotal Voting Rights
30th Oct 20202:30 pmRNSDirector/PDMR Shareholding
2nd Oct 20203:30 pmRNSDirector/PDMR Shareholding
1st Oct 20201:30 pmRNSTotal Voting Rights
17th Sep 20201:30 pmRNSHolding(s) in Company
4th Sep 20201:05 pmRNSDirector/PDMR Shareholding
2nd Sep 202012:30 pmRNSHolding(s) in Company
1st Sep 20202:00 pmRNSTotal Voting Rights
25th Aug 20209:30 amRNSAdditional Listing
7th Aug 20202:30 pmRNSDirector/PDMR Shareholding
3rd Aug 20203:55 pmRNSBlock listing Interim Review
3rd Aug 20203:05 pmRNSTotal Voting Rights
30th Jul 20205:00 pmRNSDirectors/PDMRs Shareholding
13th Jul 202012:30 pmRNSDirector/PDMR Shareholding
10th Jul 20209:00 amRNSDirector/PDMR Shareholding
9th Jul 20203:00 pmRNSHolding(s) in Company
2nd Jul 20202:15 pmRNSResult of AGM
1st Jul 202012:15 pmRNSTotal Voting Rights
1st Jul 20207:00 amRNSQ1 Trading Statement
25th Jun 20205:20 pmRNSHolding(s) in Company
23rd Jun 20209:00 amRNS2020 Annual General Meeting
12th Jun 202012:58 pmRNSDirector/PDMR Shareholding
1st Jun 20203:25 pmRNSTotal Voting Rights
1st Jun 202011:00 amRNSSimon Roberts becomes Chief Executive Officer
29th May 20201:02 pmRNSAnnual Report and Notice of AGM 2020
15th May 20202:00 pmRNSDirector/PDMR Shareholding
12th May 202010:00 amRNSDirectorate Changes
11th May 202012:45 pmRNSDirector/PDMR Shareholding
6th May 20204:00 pmRNSHolding(s) in Company
4th May 20204:00 pmRNSHolding(s) in Company
1st May 20203:30 pmRNSTotal Voting Rights
30th Apr 202010:00 amRNSBoard Committee Memberships
30th Apr 20207:00 amRNSFinal Results
27th Apr 20206:34 pmRNSDisclosure of Rights attached to Ordinary Shares
17th Apr 20205:45 pmRNSDirector/PDMR Shareholding
1st Apr 20203:00 pmRNSTotal Voting Rights
20th Mar 20204:50 pmRNSDirector/PDMR Shareholding
18th Mar 20207:00 amRNSBusiness Rates
2nd Mar 202010:25 amRNSTotal Voting Rights
26th Feb 20205:05 pmRNSDirector/PDMR Shareholding
21st Feb 202012:00 pmRNSDirector/PDMR Shareholding
12th Feb 20207:00 amRNSDirectorate Change - Sainsbury's Bank
3rd Feb 20202:30 pmRNSBlock listing Interim Review
3rd Feb 20202:30 pmRNSTotal Voting Rights
28th Jan 20207:00 amRNSJ Sainsbury plc to become Net Zero by 2040
24th Jan 202012:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.